<DOC>
	<DOCNO>NCT00974818</DOCNO>
	<brief_summary>The purpose study compare bladder cancer treatment , Mitomycin C ( MMC ) Bacillus Calmette Guerin ( BCG ) , find well . In study , patient get either Mitomycin C ( MMC ) Bacillus Calmette Guerin ( BCG ) . They get . The patient Transurethral Resection ( TUR ) office cystoscopy make diagnosis bladder cancer . A biopsy do remove tumor doctor saw . Even doctor remove tumor , cancer return . In case , doctor put medicine bladder destroy cancer cell . This call intravesical therapy . The two commonly use drug purpose MMC BCG . Both drug study many year . They show good result compare treatment . They study use schedule use study . The doctor know two drug equally effective treat cancer prevent recurrence . BCG study often MMC . The study show long schedule BCG good short schedule MMC . They also show side effect BCG intense MMC . A recent study show new dose MMC well old standard dose . Since side effect MMC occur less often , important learn whether two drug equally effective . That could help u decide treatment . In study , doctor compare MMC BCG give amount time . The doctor hop study tell u drug effective prevent return cancer .</brief_summary>
	<brief_title>Mitomycin C Versus Bacillus Calmette-Guerin Intravesical Treatment Non-Muscle-Invasive Bladder Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<mesh_term>BCG Vaccine</mesh_term>
	<criteria>Age 18 year old Patients must pathologically confirm nonmuscle invasive urothelial bladder carcinoma Department Pathology New York Presbyterian Hospital , Weill Medical College Cornell University Memorial Sloan Kettering Cancer Center document past history Ta T1 nonmuscle invasive urothelial bladder tumor . Intermediate Risk UBC patient : Recurrence Total Score = 1 9 Any intravesical therapy within past six month prior current diagnosis Currently treat schedule radiation treatment bladder cancer study Scheduled surgery bladder cancer study Currently treat schedule treatment chemotherapeutic agent study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Bladder</keyword>
	<keyword>Mitomycin C</keyword>
	<keyword>MMC</keyword>
	<keyword>TheracysR Bacillus Calmette-Guerin</keyword>
	<keyword>BCG</keyword>
	<keyword>intravesical</keyword>
	<keyword>09-118</keyword>
</DOC>